Vanderbilt investigators have characterized how a new first-in-class antibacterial drug works, which will guide the development of additional compounds that overcome antibacterial resistance.

A precise understanding of how the enzyme topoisomerase II cuts DNA could lead to better anti-cancer therapies.

Five Vanderbilt University faculty members have been elected fellows of the American Association for the Advancement of Science this year.

Vanderbilt researchers describe how certain tuberculosis treatments work and suggest these medications may overcome the threat of drug-resistant tuberculosis.

It’s not often that a keynote speaker will ask his audience to close their eyes and tune him out, but that’s what Aviad “Adi” Haramati, PhD, did when delivering the 2018 John E. Chapman Lecture.

New mechanistic details about the DNA-unwinding activity of antibacterial protein targets could lead to the design of better antibiotic medicines.

Vanderbilt University School of Medicine (VUSM) recently established the Academy for Excellence in Education Lillian B. Nanney Award for Outstanding Service to the VUSM/Vanderbilt University Medical Center (VUMC) Community of Educators.